Rho-Associated Kinase Inhibitors: Potential Future Treatments for Glaucoma.
作者信息
Daneshvar Ramin, Amini Nima
机构信息
Cornea Research Center, Mashhad University of Medical Sciences, Mashhad, Iran ; Department of Glaucoma, Khatam Eye Hospital, Mashhad, Iran.
Department of Health Sciences, California State University, Northridge, Los Angeles, CA, USA ; Department of Pathology and Laboratory Medicine, University of California, Davis Medical Center, Sacramento, California, USA.
出版信息
J Ophthalmic Vis Res. 2014 Jul-Sep;9(3):395-8. doi: 10.4103/2008-322X.143384.
Abstract
摘要
相似文献
1
Rho-Associated Kinase Inhibitors: Potential Future Treatments for Glaucoma.Rho相关激酶抑制剂：青光眼未来可能的治疗方法。
J Ophthalmic Vis Res. 2014 Jul-Sep;9(3):395-8. doi: 10.4103/2008-322X.143384.
2
Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility.Rho-kinase (ROCK) 抑制剂——以眼部应用为重点的神经保护治疗新模式。
Curr Med Chem. 2020;27(14):2222-2256. doi: 10.2174/0929867325666181031102829.
3
Discovery of novel inhibitors for the treatment of glaucoma.发现用于治疗青光眼的新型抑制剂。
Expert Opin Drug Discov. 2015 Mar;10(3):293-313. doi: 10.1517/17460441.2015.1000857. Epub 2015 Jan 9.
4
Potential role of Rho-associated protein kinase inhibitors for glaucoma treatment.Rho相关蛋白激酶抑制剂在青光眼治疗中的潜在作用。
Recent Pat Endocr Metab Immune Drug Discov. 2012 May;6(2):89-98. doi: 10.2174/187221412800604554.
5
Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595.使用 rho 激酶抑制剂治疗青光眼和眼内高压：美国专利 2018244666 和 2018256595 的专利评估。
Expert Opin Ther Pat. 2019 Oct;29(10):753-759. doi: 10.1080/13543776.2019.1658743. Epub 2019 Aug 22.
6
Rho-kinase inhibitors in the management of glaucoma.Rho 激酶抑制剂在青光眼治疗中的应用。
Expert Opin Ther Pat. 2019 Oct;29(10):817-827. doi: 10.1080/13543776.2019.1670812. Epub 2019 Oct 1.
7
Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.Rho GTP酶/Rho激酶信号通路在青光眼发病机制及治疗中的作用：从实验台到临床的研究
Exp Eye Res. 2017 May;158:23-32. doi: 10.1016/j.exer.2016.08.023. Epub 2016 Sep 1.
8
Rho-associated kinase inhibitors: a novel glaucoma therapy.Rho 相关激酶抑制剂：一种新型青光眼治疗方法。
Prog Retin Eye Res. 2013 Nov;37:1-12. doi: 10.1016/j.preteyeres.2013.05.002. Epub 2013 Jun 12.
9
Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment.Rho 相关激酶抑制剂：青光眼治疗的演进策略。
Drugs. 2019 Jul;79(10):1031-1036. doi: 10.1007/s40265-019-01130-z.
10
Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma.抑制Rho GTP酶/Rho激酶作为治疗青光眼的新靶点。
BioDrugs. 2007;21(3):167-77. doi: 10.2165/00063030-200721030-00004.
引用本文的文献
1
An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor.一项关于人眼Tenon 纤维细胞介导的瘢痕形成的体外研究：Rho 激酶抑制剂 Y-27632 的作用。
Cell Biochem Funct. 2019 Mar;37(2):113-124. doi: 10.1002/cbf.3382. Epub 2019 Feb 18.
2
A porcine ex vivo model of pigmentary glaucoma.猪眼离体模型的色素性青光眼。
Sci Rep. 2018 Apr 3;8(1):5468. doi: 10.1038/s41598-018-23861-x.
3
Estimating Human Trabecular Meshwork Stiffness by Numerical Modeling and Advanced OCT Imaging.通过数值建模和先进的光学相干断层扫描成像技术估算人小梁网的刚度
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4809-4817. doi: 10.1167/iovs.17-22175.
4
Trabecular meshwork stiffness in glaucoma.青光眼小梁网硬度
Exp Eye Res. 2017 May;158:3-12. doi: 10.1016/j.exer.2016.07.011. Epub 2016 Jul 19.
本文引用的文献
1
Canaloplasty in open-angle glaucoma surgery: a four-year follow-up.开角型青光眼手术中的小梁切开术：四年随访
ScientificWorldJournal. 2014 Jan 16;2014:469609. doi: 10.1155/2014/469609. eCollection 2014.
2
Improvement in outflow facility by two novel microinvasive glaucoma surgery implants.两种新型微创青光眼手术植入物对房水流出量的改善作用。
Invest Ophthalmol Vis Sci. 2014 Mar 28;55(3):1893-900. doi: 10.1167/iovs.13-13353.
3
Cytoskeleton changes of airway smooth muscle cells in juvenile rats with airway remodeling in asthma and the RhoA/ROCK signaling pathway mechanism.哮喘气道重塑幼年大鼠气道平滑肌细胞的细胞骨架变化及RhoA/ROCK信号通路机制
Genet Mol Res. 2014 Jan 22;13(1):559-69. doi: 10.4238/2014.January.22.2.
4
AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.AMA0076，一种新型局部作用的 Rho 激酶抑制剂，可显著降低新西兰白兔的眼内压，且极少引起充血。
Invest Ophthalmol Vis Sci. 2014 Feb 18;55(2):1006-16. doi: 10.1167/iovs.13-13157.
5
Morphological and hydrodynamic correlations with increasing outflow facility by rho-kinase inhibitor Y-27632.通过 rho 激酶抑制剂 Y-27632 增加流出道顺应性的形态学和流体动力学相关性。
J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):143-53. doi: 10.1089/jop.2013.0192. Epub 2014 Jan 24.
6
Prospective, unmasked evaluation of the iStent® inject system for open-angle glaucoma: synergy trial.前瞻性、非盲法评价 iStent® 注射系统治疗开角型青光眼：协同试验。
Adv Ther. 2014 Feb;31(2):189-201. doi: 10.1007/s12325-014-0095-y. Epub 2014 Jan 23.
7
IOP-lowering effect of isoquinoline-5-sulfonamide compounds in ocular normotensive monkeys.异喹啉-5-磺酰胺化合物对正常眼压猴的降眼压作用。
Bioorg Med Chem Lett. 2014 Feb 1;24(3):831-4. doi: 10.1016/j.bmcl.2013.12.085. Epub 2013 Dec 25.
8
Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants.微创青光眼手术（MIGS）及新型植入物的最新进展
J Ophthalmol. 2013;2013:705915. doi: 10.1155/2013/705915. Epub 2013 Nov 27.
9
Trabectome surgery for primary and secondary open angle glaucomas.经巩膜睫状体通路分流器手术治疗原发性和继发性开角型青光眼。
Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2753-60. doi: 10.1007/s00417-013-2500-7. Epub 2013 Oct 26.
10
Involvement of cyclin D and p27 in cell proliferation mediated by ROCK inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing.ROCK 抑制剂 Y-27632 和 Y-39983 介导的细胞增殖中环蛋白 D 和 p27 的参与角膜内皮伤口愈合。
Invest Ophthalmol Vis Sci. 2014 Jan 15;55(1):318-29. doi: 10.1167/iovs.13-12225.
Zotero 插件